California Patent of the Month – May 2023

LifeWave Biomedical, Inc. has targeted their medical expertise on the mission of developing a connected health solution that improves the clinical management of patients living with congestive heart failure (CHF) in hospital, ambulatory, and home settings. As they work towards this mission, the company has developed proprietary technology which supports their device’s functionality, an approach which has recently resulted in a patent.

The patented technology makes it possible to determine a change in the spatial configuration of a heart. The device includes a low pulse repetition frequency transmitter, antenna, and a swept-range receiver. Designed to be positioned externally, the device offers a non-invasive method to collect data from targeted portions of the heart.

LifeWave’s device transmits ultra wideband signals which are very low energy (similar to Bluetooth energy levels) which propagate into the human body. The heart beats, returning radiofrequency waves which are read as reflexion signals. The antenna is located adjacent to the heart, and the processor reads these reflection signals, comparing them against predetermined heart chamber dimensions. This data is then used to determine cardiac chamber volume based on positions of heart wall excursions and the presumed dimensions of a heart chamber.

It’s able to capture and prioritize signals with respect to minimum discontinuities. This means that it can identify signals that qualify for further analysis by integrating a predetermined number of reflections for a range of interest within the target range of interest. 

LifeWave Biomedical’s new technology can improve the diagnosis and treatment of heart conditions by providing physicians with accurate data on the heart’s motion and volume. The LifeWave technology is safe for full-time usage and skin contact and meets all FDA human safety and Federal Communications Commission (FCC) regulations governing human RF exposure. It is a significant innovation in the field of medical devices and has the potential to save lives.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Are you eligible?

R&D Tax Credit Eligibility AI Tool

Why choose us?

directive for LBI taxpayers

Pass an Audit?

directive for LBI taxpayers

What is the R&D Tax Credit?

The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.

Never miss a deadline again

directive for LBI taxpayers

Stay up to date on IRS processes

Discover R&D in your industry

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/

R&D Tax Credit Training for CPAs

directive for LBI taxpayers

Upcoming Webinars

R&D Tax Credit Training for CFPs

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinars

R&D Tax Credit Training for SMBs

water tech

Upcoming Webinars

Choose your state

find-us-map

Recent Posts